On September 27, Dr. Xiang Hua, Director, Co-founder, and Deputy General Manager of Shenzhen Cell Valley, along with Ms. Sun Rui, Head of the Marketing Department, accompanied a delegation from the Hospital Authority of Hong Kong, led by Dr. Su Jieying, Director of the Hong Kong Island East Cluster. The group visited Shenzhen Nanshan People's Hospital (hereinafter referred to as "Nanshan Hospital") and Peking University Shenzhen Hospital (hereinafter referred to as "PKU Shenzhen Hospital").The visit aimed to leverage Shenzhen Cell Valley's unique advantages as a supply platform for cell therapy products. By joining forces with leading medical institutions in both Hong Kong and Shenzhen that possess cutting-edge technologies, the parties seek to jointly advance the clinical research and practical application of cell therapy products.

At the symposium held at Nanshan Hospital, Vice President Liu Yansong, Section Chief Chen Chuanhuang of the Science and Education Department, and Director Guo Zhi of the Hematology Department extended a warm welcome to the guests from Shenzhen and Hong Kong. During the meeting, the three parties engaged in in-depth discussions focusing on current international trends in cell and gene therapy, as well as potential opportunities for future cooperation between Shenzhen and Hong Kong.Additionally, Dean Wang Qiang from the Medical Department of Wuhan University of Science and Technology attended the meeting online. He and Professor Guo Zhi provided a detailed introduction to several multi-center Investigator-Initiated Trial (IIT) research projects led by their institution, offering valuable research insights and sharing significant experience.

At the symposium held at Peking University Shenzhen Hospital, a team of experts gathered, including Vice President Zhao Yongsheng, Director Shi Yu of the Research and Teaching Department, Director Zhang Hongyu of the Hematology Department, and Director Chen Junhui of the Interventional Radiology Department.During the meeting, the delegation from the Hospital Authority of Hong Kong formally introduced the Hong Kong Island East Cluster. As the largest hospital cluster in Hong Kong, it encompasses a wide range of facilities, including seven public hospitals, seven specialist outpatient clinics, and twelve general outpatient clinics. The cluster is dedicated not only to providing comprehensive and specialized medical services but also to driving innovative developments in smart hospital services.Subsequently, our company shared Shenzhen Cell Valley's latest research achievements and clinical application cases in the field of cell therapy. Special emphasis was placed on our independently developed and successfully launched series of non-engineered allogeneic NK cell therapy products, as well as various CAR-T cell products utilizing advanced retroviral vector technologies, all of which have achieved significant breakthroughs. Currently, these product series have established deep collaborative partnerships with multiple medical institutions and have demonstrated tangible efficacy and validation in clinical practice.

At the conclusion of the symposium, the three parties exchanged insights on clinical application experiences and patient management strategies in cell therapy. They also explored potential opportunities for future collaboration in scientific research, talent development, and technology translation.

This joint visit by our company and the Hospital Authority of Hong Kong has not only deepened mutual understanding and trust but also facilitated in-depth exchanges and learning between the Hong Kong delegation and the two hospitals. The discussions focused primarily on patient management strategies and response measures during the clinical application of cell therapy products, aiming to further enhance the safety and efficacy of clinical practices. We are confident that, through the joint efforts of both Shenzhen and Hong Kong, we will effectively promote coordinated development in the field of cell therapy across both regions, delivering higher-quality and more efficient medical services to their residents.